Chlorine in PDB 7qa0: Crystal Structure of Pqsr (Mvfr) Ligand-Binding Domain in Complex with Compound 1456
Protein crystallography data
The structure of Crystal Structure of Pqsr (Mvfr) Ligand-Binding Domain in Complex with Compound 1456, PDB code: 7qa0
was solved by
S.Schmelz,
W.Blankenfeldt,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
54.57 /
2.67
|
Space group
|
C 2 2 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
109.131,
119.824,
114.033,
90,
90,
90
|
R / Rfree (%)
|
23.6 /
28.1
|
Other elements in 7qa0:
The structure of Crystal Structure of Pqsr (Mvfr) Ligand-Binding Domain in Complex with Compound 1456 also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Pqsr (Mvfr) Ligand-Binding Domain in Complex with Compound 1456
(pdb code 7qa0). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the
Crystal Structure of Pqsr (Mvfr) Ligand-Binding Domain in Complex with Compound 1456, PDB code: 7qa0:
Jump to Chlorine binding site number:
1;
2;
Chlorine binding site 1 out
of 2 in 7qa0
Go back to
Chlorine Binding Sites List in 7qa0
Chlorine binding site 1 out
of 2 in the Crystal Structure of Pqsr (Mvfr) Ligand-Binding Domain in Complex with Compound 1456
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of Pqsr (Mvfr) Ligand-Binding Domain in Complex with Compound 1456 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl401
b:107.6
occ:1.00
|
CL1
|
A:9ZL401
|
0.0
|
107.6
|
1.0
|
C22
|
A:9ZL401
|
1.8
|
70.8
|
1.0
|
C23
|
A:9ZL401
|
2.7
|
71.0
|
1.0
|
H231
|
A:9ZL401
|
2.8
|
88.5
|
1.0
|
C21
|
A:9ZL401
|
2.8
|
64.5
|
1.0
|
HD13
|
A:LEU189
|
2.8
|
96.5
|
1.0
|
O25
|
A:9ZL401
|
3.1
|
79.0
|
1.0
|
HG21
|
A:VAL211
|
3.1
|
65.3
|
1.0
|
HH2
|
A:TRP234
|
3.2
|
51.2
|
1.0
|
HG21
|
A:VAL170
|
3.2
|
38.1
|
1.0
|
CH2
|
A:TRP234
|
3.5
|
40.0
|
1.0
|
HZ3
|
A:TRP234
|
3.5
|
52.3
|
1.0
|
H283
|
A:9ZL401
|
3.6
|
87.2
|
1.0
|
CZ3
|
A:TRP234
|
3.7
|
40.8
|
1.0
|
CD1
|
A:LEU189
|
3.8
|
77.7
|
1.0
|
HG22
|
A:VAL170
|
3.9
|
38.1
|
1.0
|
CG2
|
A:VAL170
|
4.0
|
29.0
|
1.0
|
C18
|
A:9ZL401
|
4.0
|
52.8
|
1.0
|
H282
|
A:9ZL401
|
4.0
|
87.2
|
1.0
|
HG11
|
A:VAL211
|
4.1
|
96.7
|
1.0
|
HD22
|
A:LEU189
|
4.1
|
64.5
|
1.0
|
C20
|
A:9ZL401
|
4.1
|
71.5
|
1.0
|
CG2
|
A:VAL211
|
4.1
|
51.7
|
1.0
|
C28
|
A:9ZL401
|
4.1
|
69.9
|
1.0
|
HG11
|
A:VAL170
|
4.1
|
29.5
|
1.0
|
C26
|
A:9ZL401
|
4.1
|
78.3
|
1.0
|
HD12
|
A:LEU189
|
4.2
|
96.5
|
1.0
|
HD11
|
A:ILE236
|
4.2
|
82.1
|
1.0
|
HG12
|
A:ILE236
|
4.2
|
82.5
|
1.0
|
HD11
|
A:LEU189
|
4.2
|
96.5
|
1.0
|
HB2
|
A:LEU189
|
4.2
|
65.5
|
1.0
|
HG22
|
A:ILE186
|
4.3
|
79.8
|
1.0
|
CZ2
|
A:TRP234
|
4.3
|
39.6
|
1.0
|
HG23
|
A:VAL211
|
4.4
|
65.3
|
1.0
|
HG22
|
A:VAL211
|
4.5
|
65.3
|
1.0
|
HG23
|
A:VAL170
|
4.5
|
38.1
|
1.0
|
C19
|
A:9ZL401
|
4.6
|
65.1
|
1.0
|
HZ2
|
A:TRP234
|
4.6
|
50.8
|
1.0
|
H261
|
A:9ZL401
|
4.6
|
97.2
|
1.0
|
HB3
|
A:LEU189
|
4.7
|
65.5
|
1.0
|
CG
|
A:LEU189
|
4.7
|
43.5
|
1.0
|
HG13
|
A:VAL170
|
4.7
|
29.5
|
1.0
|
CE3
|
A:TRP234
|
4.7
|
48.6
|
1.0
|
HA
|
A:ILE186
|
4.7
|
94.4
|
1.0
|
CB
|
A:LEU189
|
4.7
|
51.8
|
1.0
|
CG1
|
A:VAL170
|
4.8
|
21.9
|
1.0
|
CD2
|
A:LEU189
|
4.8
|
51.0
|
1.0
|
CG1
|
A:VAL211
|
4.8
|
77.9
|
1.0
|
H201
|
A:9ZL401
|
4.8
|
89.0
|
1.0
|
CD1
|
A:ILE236
|
4.9
|
65.7
|
1.0
|
CG1
|
A:ILE236
|
4.9
|
66.0
|
1.0
|
HG13
|
A:VAL211
|
4.9
|
96.7
|
1.0
|
CB
|
A:VAL211
|
5.0
|
73.0
|
1.0
|
|
Chlorine binding site 2 out
of 2 in 7qa0
Go back to
Chlorine Binding Sites List in 7qa0
Chlorine binding site 2 out
of 2 in the Crystal Structure of Pqsr (Mvfr) Ligand-Binding Domain in Complex with Compound 1456
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of Pqsr (Mvfr) Ligand-Binding Domain in Complex with Compound 1456 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl401
b:120.8
occ:1.00
|
CL1
|
B:9ZL401
|
0.0
|
120.8
|
1.0
|
C22
|
B:9ZL401
|
1.8
|
81.7
|
1.0
|
C23
|
B:9ZL401
|
2.7
|
65.4
|
1.0
|
C21
|
B:9ZL401
|
2.8
|
62.1
|
1.0
|
H231
|
B:9ZL401
|
2.8
|
81.7
|
1.0
|
O25
|
B:9ZL401
|
3.0
|
56.8
|
1.0
|
HD13
|
B:LEU189
|
3.1
|
91.7
|
1.0
|
HD12
|
B:LEU189
|
3.4
|
91.7
|
1.0
|
HG21
|
B:VAL211
|
3.4
|
100.2
|
1.0
|
HH2
|
B:TRP234
|
3.6
|
61.0
|
1.0
|
HG11
|
B:VAL211
|
3.6
|
112.0
|
1.0
|
CD1
|
B:LEU189
|
3.7
|
73.7
|
1.0
|
HG21
|
B:VAL170
|
3.7
|
45.6
|
1.0
|
CH2
|
B:TRP234
|
3.8
|
48.2
|
1.0
|
H283
|
B:9ZL401
|
3.8
|
46.9
|
1.0
|
HZ3
|
B:TRP234
|
3.8
|
46.5
|
1.0
|
CZ3
|
B:TRP234
|
3.9
|
36.0
|
1.0
|
HG13
|
B:ILE186
|
4.0
|
82.6
|
1.0
|
C18
|
B:9ZL401
|
4.0
|
57.0
|
1.0
|
C20
|
B:9ZL401
|
4.0
|
55.0
|
1.0
|
HA
|
B:ILE186
|
4.1
|
106.0
|
1.0
|
HB2
|
B:LEU189
|
4.2
|
91.1
|
1.0
|
C26
|
B:9ZL401
|
4.2
|
49.0
|
1.0
|
HG11
|
B:VAL170
|
4.2
|
57.1
|
1.0
|
HD11
|
B:LEU189
|
4.3
|
91.7
|
1.0
|
H281
|
B:9ZL401
|
4.3
|
46.9
|
1.0
|
C28
|
B:9ZL401
|
4.3
|
36.4
|
1.0
|
CG2
|
B:VAL211
|
4.4
|
80.8
|
1.0
|
HG22
|
B:VAL170
|
4.4
|
45.6
|
1.0
|
HB3
|
B:LEU189
|
4.5
|
91.1
|
1.0
|
CG2
|
B:VAL170
|
4.5
|
35.3
|
1.0
|
CG1
|
B:VAL211
|
4.5
|
90.6
|
1.0
|
CZ2
|
B:TRP234
|
4.5
|
58.9
|
1.0
|
C19
|
B:9ZL401
|
4.6
|
50.0
|
1.0
|
HD11
|
B:ILE236
|
4.6
|
30.9
|
1.0
|
HB
|
B:ILE186
|
4.7
|
105.1
|
1.0
|
HG22
|
B:VAL211
|
4.7
|
100.2
|
1.0
|
CB
|
B:LEU189
|
4.7
|
73.2
|
1.0
|
H201
|
B:9ZL401
|
4.8
|
69.3
|
1.0
|
HG13
|
B:VAL211
|
4.8
|
112.0
|
1.0
|
CE3
|
B:TRP234
|
4.8
|
36.1
|
1.0
|
H261
|
B:9ZL401
|
4.8
|
62.0
|
1.0
|
CG1
|
B:ILE186
|
4.8
|
66.1
|
1.0
|
HZ2
|
B:TRP234
|
4.8
|
73.9
|
1.0
|
CG
|
B:LEU189
|
4.8
|
81.8
|
1.0
|
HG13
|
B:VAL170
|
4.9
|
57.1
|
1.0
|
H273
|
B:9ZL401
|
4.9
|
96.3
|
1.0
|
HD12
|
B:ILE186
|
4.9
|
91.7
|
1.0
|
CB
|
B:VAL211
|
4.9
|
81.2
|
1.0
|
CG1
|
B:VAL170
|
5.0
|
44.9
|
1.0
|
CA
|
B:ILE186
|
5.0
|
85.7
|
1.0
|
HG23
|
B:VAL211
|
5.0
|
100.2
|
1.0
|
HB
|
B:VAL211
|
5.0
|
100.7
|
1.0
|
|
Reference:
W.Blankenfeldt,
S.Schmelz.
Divergent Synthesis and Biological Evaluation of Inverse Agonists Targeting Pqsr To Be Published.
Page generated: Tue Jul 30 03:10:49 2024
|